|
1
|
Lin QJ, Yang F, Jin C and Fu DL: Current
status and progress of pancreatic cancer in China. World J
Gastroenterol. 21:7988–8003. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Warshaw AL and Fernández-del Castillo C:
Pancreatic carcinoma. N Engl J Med. 326:455–465. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Li D, Xie K, Wolff R and Abbruzzese JL:
Pancreatic cancer. Lancet. 363:1049–1057. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hruban RH, Maitra A and Goggins M: Update
on pancreatic intraepithelial neoplasia. Int J Clin Exp Pathol.
1:306–316. 2008.PubMed/NCBI
|
|
5
|
Feldmann G, Beaty R, Hruban RH and Maitra
A: Molecular genetics of pancreatic intraepithelial neoplasia. J
Hepatobiliary Pancreat Surg. 14:224–232. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Korc M: Pancreatic cancer-associated
stroma production. Am J Surg. 194 4 Suppl:S84–S86. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Miyamoto H, Murakami T, Tsuchida K, Sugino
H, Miyake H and Tashiro S: Tumor-stroma interaction of human
pancreatic cancer: Acquired resistance to anticancer drugs and
proliferation regulation is dependent on extracellular matrix
proteins. Pancreas. 28:38–44. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
De Wever O and Mareel M: Role of tissue
stroma in cancer cell invasion. J Pathol. 200:429–447. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ding K, Lopez-Burks M, Sanchez-Duran JA,
Korc M and Lander AD: Growth factor-induced shedding of syndecan-1
confers glypican-1 dependence on mitogenic responses of cancer
cells. J Cell Biol. 171:729–738. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kleeff J, Ishiwata T, Kumbasar A, Friess
H, Büchler MW, Lander AD and Korc M: The cell-surface heparan
sulfate proteoglycan glypican-1 regulates growth factor action in
pancreatic carcinoma cells and is overexpressed in human pancreatic
cancer. J Clin Invest. 102:1662–1673. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Bailey P, Chang DK, Nones K, Johns AL,
Patch AM, Gingras MC, Miller DK, Christ AN, Bruxner TJ, Quinn MC,
et al: Genomic analyses identify molecular subtypes of pancreatic
cancer. Nature. 531:47–52. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Waddell N, Pajic M, Patch AM, Chang DK,
Kassahn KS, Bailey P, Johns AL, Miller D, Nones K, Quek K, et al:
Whole genomes redefine the mutational landscape of pancreatic
cancer. Nature. 518:495–501. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Edgar R, Domrachev M and Lash AE: Gene
Expression Omnibus: NCBI gene expression and hybridization array
data repository. Nucleic Acids Res. 30:207–210. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ishii M, Shimizu S, Hagiwara T, Wajima T,
Miyazaki A, Mori Y and Kiuchi Y: Extracellular-added ADP-ribose
increases intracellular free Ca2+ concentration through Ca2+
release from stores, but not through TRPM2-mediated Ca2+ entry, in
rat beta-cell line RIN-5F. J Pharmacol Sci. 101:174–178. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Inamura K, Sano Y, Mochizuki S, Yokoi H,
Miyake A, Nozawa K, Kitada C, Matsushime H and Furuichi K: Response
to ADP-ribose by activation of TRPM2 in the CRI-G1 insulinoma cell
line. J Membr Biol. 191:201–207. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhang W, Chu X, Tong Q, Cheung JY, Conrad
K, Masker K and Miller BA: A novel TRPM2 isoform inhibits calcium
influx and susceptibility to cell death. J Biol Chem.
278:16222–16229. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ishii M, Hagiwara T, Mori Y and Shimizu S:
Involvement of TRPM2 and L-type Ca2* channels in
Ca2* entry and cell death induced by hydrogen peroxide
in rat β-cell line RIN-5F. J Toxicol Sci. 39:199–209. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Tao KY, Li XX, Xu WZ, Wang Y, Zhu SM, Xie
HX, Luo WH, Xu YJ and Xu XL: Prognostic role of apoptosis-related
gene functional variants in advanced non-small-cell lung cancer
patients treated with first-line platinum-based chemotherapy. Onco
Targets Ther. 8:147–155. 2015.PubMed/NCBI
|
|
20
|
Orfanelli U, Jachetti E, Chiacchiera F,
Grioni M, Brambilla P, Briganti A, Freschi M, Martinelli-Boneschi
F, Doglioni C, Montorsi F, et al: Antisense transcription at the
TRPM2 locus as a novel prognostic marker and therapeutic target in
prostate cancer. Oncogene. 34:2094–2102. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Huang C, Qin Y, Liu H, Liang N, Chen Y, Ma
D, Han Z, Xu X, Zhou X, He J and Li S: Downregulation of a novel
long noncoding RNA TRPM2-AS promotes apoptosis in non-small cell
lung cancer. Tumour Biol. 39:10104283176911912017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wang F, Jin R, Zou BB, Li L, Cheng FW, Luo
X, Geng X and Zhang SQ: Activation of Toll-like receptor 7
regulates the expression of IFN-λ1, p53, PTEN, VEGF, TIMP-1 and
MMP-9 in pancreatic cancer cells. Mol Med Rep. 13:1807–1812. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Grimmig T, Matthes N, Hoeland K, Tripathi
S, Chandraker A, Grimm M, Moench R, Moll EM, Friess H, Tsaur I, et
al: TLR7 and TLR8 expression increases tumor cell proliferation and
promotes chemoresistance in human pancreatic cancer. Int J Oncol.
47:857–866. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Eigenbrod T and Dalpke AH: TLR7
inhibition: A novel strategy for pancreatic cancer treatment?
JAKSTAT. 2:e230112013.PubMed/NCBI
|
|
25
|
Ochi A, Graffeo CS, Zambirinis CP, Rehman
A, Hackman M, Fallon N, Barilla RM, Henning JR, Jamal M, Rao R, et
al: Toll-like receptor 7 regulates pancreatic carcinogenesis in
mice and humans. J Clin Invest. 122:4118–4129. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Vaz J and Andersson R: Intervention on
toll-like receptors in pancreatic cancer. World J Gastroenterol.
20:5808–5817. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ni IB, Ching NC, Meng CK and Zakaria Z:
Translocation t(11;14)(q13;q32) and genomic imbalances in
multi-ethnic multiple myeloma patients: A Malaysian study. Hematol
Rep. 4:e192012.PubMed/NCBI
|
|
28
|
Danger R, Thervet E, Grisoni ML, Puig PL,
Pallier A, Tregouet D, Lecorre D, Giral M, Legendre C, Soulillou JP
and Brouard S: PARVG gene polymorphism and operational renal
allograft tolerance. Transplant Proc. 44:2845–2848. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Chen G, Wang Y, Wang L and Xu W:
Identifying prognostic biomarkers based on aberrant DNA methylation
in kidney renal clear cell carcinoma. Oncotarget. 8:5268–5280.
2017.PubMed/NCBI
|
|
30
|
Zhou J, Leu NA, Eckardt S, McLaughlin KJ
and Wang PJ: STK31/TDRD8, a germ cell-specific factor, is
dispensable for reproduction in mice. PLoS One. 9:e894712014.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Kotov AA, Akulenko NV, Kibanov MV and
Olenina LV: Dead-box RNA helicases in animal gametogenesis. Mol
Biol (Mosk). 48:22–35. 2014.(In Russian). View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Lim AK, Lorthongpanich C, Chew TG, Tan CW,
Shue YT, Balu S, Gounko N, Kuramochi-Miyagawa S, Matzuk MM, Chuma
S, et al: The nuage mediates retrotransposon silencing in mouse
primordial ovarian follicles. Development. 140:3819–3825. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Lee K, Na W, Maeng JH, Wu H and Ju BG:
Regulation of DU145 prostate cancer cell growth by Scm-like with
four mbt domains 2. J Biosci. 38:105–112. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Gwak J, Shin JY, Lee K, Hong SK, Oh S, Goh
SH, Kim WS and Ju BG: SFMBT2 (Scm-like with four mbt domains 2)
negatively regulates cell migration and invasion in prostate cancer
cells. Oncotarget. 7:48250–48264. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Li F, Abuarab N and Sivaprasadarao A:
Reciprocal regulation of actin cytoskeleton remodelling and cell
migration by Ca2+ and Zn2+: Role of TRPM2 channels. J Cell Sci.
129:2016–2029. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Bauer I, Grozio A, Lasigliè D, Basile G,
Sturla L, Magnone M, Sociali G, Soncini D, Caffa I, Poggi A, et al:
The NAD+-dependent histone deacetylase SIRT6 promotes cytokine
production and migration in pancreatic cancer cells by regulating
Ca2+ responses. J Biol Chem. 287:40924–40937. 2012. View Article : Google Scholar : PubMed/NCBI
|
